Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

HIV care in times of the COVID-19 crisis - Where are we now in Central and Eastern Europe?

JD. Kowalska, A. Skrzat-Klapaczyńska, D. Bursa, T. Balayan, J. Begovac, N. Chkhartishvili, D. Gokengin, A. Harxhi, D. Jilich, D. Jevtovic, K. Kase, B. Lakatos, R. Matulionyte, V. Mulabdic, A. Nagit, A. Papadopoulos, M. Stefanovic, A. Vassilenko,...

. 2020 ; 96 (-) : 311-314. [pub] 20200511

Jazyk angličtina Země Kanada

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20024926

INTRODUCTION: The SARS-CoV-2 pandemic has hit the European region disproportionately. Many HIV clinics share staff and logistics with infectious disease facilities, which are now on the frontline in tackling COVID-19. Therefore, this study investigated the impact of the current pandemic situation on HIV care and continuity of antiretroviral treatment (ART) supplies in CEE countries. METHODS: The Euroguidelines in Central and Eastern Europe (ECEE) Network Group was established in February 2016 to review standards of care for HIV in the region. The group consists of professionals actively involved in HIV care. On March 19, 2020 we decided to review the status of HIV care sustainability in the face of the emerging SARS-CoV-2 pandemic in Europe. For this purpose, we constructed an online survey consisting of 23 questions. Respondents were recruited from ECEE members in 22 countries, based on their involvement in HIV care, and contacted via email. RESULTS: In total, 19 countries responded: Albania, Armenia, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Greece, Hungary, Lithuania, Macedonia, Poland, Republic of Moldova, Russia, Serbia, Turkey, and Ukraine. Most of the respondents were infectious disease physicians directly involved in HIV care (17/19). No country reported HIV clinic closures. HIV clinics were operating normally in only six countries (31.6%). In 11 countries (57.9%) physicians were sharing HIV and COVID-19 care duties. None of the countries expected shortage of ART in the following 2 weeks; however, five physicians expressed uncertainty about the following 2 months. At the time of providing responses, ten countries (52.6%) had HIV-positive persons under quarantine. CONCLUSIONS: A shortage of resources is evident, with an impact on HIV care inevitable. We need to prepare to operate with minimal medical resources, with the aim of securing constant supplies of ART. Non-governmental organizations should re-evaluate their earlier objectives and support efforts to ensure continuity of ART delivery.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20024926
003      
CZ-PrNML
005      
20201222160036.0
007      
ta
008      
201125s2020 xxc f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijid.2020.05.013 $2 doi
035    __
$a (PubMed)32413608
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxc
100    1_
$a Kowalska, J D $u Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, Poland. Electronic address: jdkowalska@gmail.com.
245    10
$a HIV care in times of the COVID-19 crisis - Where are we now in Central and Eastern Europe? / $c JD. Kowalska, A. Skrzat-Klapaczyńska, D. Bursa, T. Balayan, J. Begovac, N. Chkhartishvili, D. Gokengin, A. Harxhi, D. Jilich, D. Jevtovic, K. Kase, B. Lakatos, R. Matulionyte, V. Mulabdic, A. Nagit, A. Papadopoulos, M. Stefanovic, A. Vassilenko, M. Vasylyev, N. Yancheva, O. Yurin, A. Horban, ECEE Network Group,
520    9_
$a INTRODUCTION: The SARS-CoV-2 pandemic has hit the European region disproportionately. Many HIV clinics share staff and logistics with infectious disease facilities, which are now on the frontline in tackling COVID-19. Therefore, this study investigated the impact of the current pandemic situation on HIV care and continuity of antiretroviral treatment (ART) supplies in CEE countries. METHODS: The Euroguidelines in Central and Eastern Europe (ECEE) Network Group was established in February 2016 to review standards of care for HIV in the region. The group consists of professionals actively involved in HIV care. On March 19, 2020 we decided to review the status of HIV care sustainability in the face of the emerging SARS-CoV-2 pandemic in Europe. For this purpose, we constructed an online survey consisting of 23 questions. Respondents were recruited from ECEE members in 22 countries, based on their involvement in HIV care, and contacted via email. RESULTS: In total, 19 countries responded: Albania, Armenia, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Greece, Hungary, Lithuania, Macedonia, Poland, Republic of Moldova, Russia, Serbia, Turkey, and Ukraine. Most of the respondents were infectious disease physicians directly involved in HIV care (17/19). No country reported HIV clinic closures. HIV clinics were operating normally in only six countries (31.6%). In 11 countries (57.9%) physicians were sharing HIV and COVID-19 care duties. None of the countries expected shortage of ART in the following 2 weeks; however, five physicians expressed uncertainty about the following 2 months. At the time of providing responses, ten countries (52.6%) had HIV-positive persons under quarantine. CONCLUSIONS: A shortage of resources is evident, with an impact on HIV care inevitable. We need to prepare to operate with minimal medical resources, with the aim of securing constant supplies of ART. Non-governmental organizations should re-evaluate their earlier objectives and support efforts to ensure continuity of ART delivery.
650    _2
$a látky proti HIV $x terapeutické užití $7 D019380
650    12
$a Betacoronavirus $7 D000073640
650    _2
$a koronavirové infekce $x epidemiologie $7 D018352
650    _2
$a HIV infekce $x farmakoterapie $7 D015658
650    _2
$a lidé $7 D006801
650    _2
$a pandemie $7 D058873
650    _2
$a virová pneumonie $x epidemiologie $7 D011024
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Skrzat-Klapaczyńska, A $u Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, Poland.
700    1_
$a Bursa, D $u Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, Poland.
700    1_
$a Balayan, T $u National Center for Disease Control and Prevention, Armenia.
700    1_
$a Begovac, J $u University Hospital for Infectious Diseases, University of Zagreb, School of Medicine, Croatia.
700    1_
$a Chkhartishvili, N $u Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
700    1_
$a Gokengin, D $u Ege University Faculty of Medicine Department of Infectious Diseases and Clinical Microbiology, Turkey.
700    1_
$a Harxhi, A $u University Hospital Center of Tirana, Infectious Disease Service, Albania.
700    1_
$a Jilich, D $u Department of Infectious Diseases, Charles University in Prague and Na Bulovce Hospital, Czech Republic.
700    1_
$a Jevtovic, D $u Belgrade University School of Medicine, Infectious Disease Hospital, Serbia.
700    1_
$a Kase, K $u West Tallinn Central Hospital, Estonia.
700    1_
$a Lakatos, B $u National Institute of Hematology and Infectious Diseases, South-Pest Central Hospital, National Center of HIV, Hungary.
700    1_
$a Matulionyte, R $u Vilnius University, Faculty of Medicine, Vilnius University Hospital Santaros Klinikos, Lithuania.
700    1_
$a Mulabdic, V $u Clinic for Infectious Diseases, Clinical Center, University of Sarajevo, Bosnia and Herzegovina.
700    1_
$a Nagit, A $u Hospital of Dermatology and Communicable Diseases, Republic of Moldova.
700    1_
$a Papadopoulos, A $u University General Hospital 'Attikon', Chaidari, Athens, Greece.
700    1_
$a Stefanovic, M $u University Clinic for Infectious Diseases and Febrile Conditions, Macedonia.
700    1_
$a Vassilenko, A $u Belarusian State Medical University, Minsk, Belarus.
700    1_
$a Vasylyev, M $u Lviv Regional Public Health Center, Ukraine.
700    1_
$a Yancheva, N $u Department for AIDS, Specialized Hospital for Active Treatment of Infectious and Parasitic Disease, Sofia, Bulgaria.
700    1_
$a Yurin, O $u Central Research Institute of Epidemiology, Russia.
700    1_
$a Horban, A $u Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, Poland.
710    2_
$a ECEE Network Group
773    0_
$w MED00005677 $t International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases $x 1878-3511 $g Roč. 96, č. - (2020), s. 311-314
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32413608 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222160032 $b ABA008
999    __
$a ok $b bmc $g 1599071 $s 1115612
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 96 $c - $d 311-314 $e 20200511 $i 1878-3511 $m International journal of infectious diseases $n Int J Infect Dis $x MED00005677
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace